Trials / Sponsors / Anaveon AG
Anaveon AG
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | A Study Evaluating ANV600 Single Agent or in Combination With Pembrolizumab in Participants With Advanced Soli Advanced Solid Tumor | Phase 1 / Phase 2 | 2024-07-01 |
| Terminated | A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2) Multiple Myeloma, Relapsed Cancer, Refractory Multiple Myeloma | Phase 1 | 2023-02-10 |
| Completed | A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1 Melanoma (Skin), Cutaneous Melanoma, Adult Disease | Phase 1 / Phase 2 | 2022-12-16 |
| Completed | A Study Evaluating Safety and Therapeutic Activity of ANV419 in Patients with Advanced Cancer. Advanced Solid Tumor, Adult Disease, Lung Cancer | Phase 1 | 2021-05-25 |